A longitudinal analysis of brain volume changes in myelin oligodendrocyte glycoprotein antibody-associated disease

- Amin, Mohammad, Al-Iedani, Oun, Lea, Rodney A., Brilot, Fabienne, Maltby, Vicki E., Lechner-Scott, Jeannette

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

- Lal, Anoushka P., Foong, Yi Chao, Roos, Izanne, Lechner-Scott, Jeannette, John, Nevin, Soysal, Aysun, D’Amico, Emanuele, Gouider, Riadh, Mrabet, Saloua, Gross-Paju, Katrin, Cárdenas‑Robledo, Simón, Moghadasi, Abdorreza Naser, Sanfilippo, Paul G., Sa, Maria Jose, Gray, Orla, Oh, Jiwon, Reddel, Stephen, Ramanathan, Sudarshini, Al-Harbi, Talal, Altintas, Ayse, Hardy, Todd A., Ozakbas, Serkan, Alroughani, Raed, Spelman, Tim, Kermode, Allan G., Surcinelli, Andrea, Laureys, Guy, Eichau, Sara, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Hodgkinson, Suzanne, Ramo-Tello, Cristina, Maimone, Davide, Rath, Louise, McCombe, Pamela, Spitaleri, Daniele, Sanchez-Menoyo, Jose Luis, Yetkin, Mehmet Fatih, Baghbanian, Seyed Mohammad, Karabudak, Rana, Al-Asmi, Abdullah, Jakob, Gregor Brecl, Khoury, Samia J., Etemadifar, Masoud, Levitz, David, van Pesch, Vincent, Buzzard, Katherine, Taylor, Bruce, Butzkueven, Helmut, Van der Walt, Anneke, Fabis-Pedrini, Marzena, Foschi, Matteo, Habek, Mario, Kalincik, Tomas

A pro-inflammatory diet is associated with long-term depression and anxiety levels but not fatigue in people with multiple sclerosis

- Saul, A., Taylor, B. V., Lechner-Scott, J., van der Mei, I., Blizzard, L., Simpson-Yap, S., Oddy, W. H., Shivappa, N., Hebert, J. R., Black, L. J., Ponsonby, A. L., Broadley, S. A.

Chronic fatigue syndrome and multiple sclerosis have reduced craniospinal compliance and dilated pressurized bridging cortical veins

- Bateman, Grant A., Bateman, Alexander R.

Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60

- Foong, Yi Chao, Merlo, Daniel, Patti, Francesco, Grammond, Pierre, Amato, Maria Pia, Kalincik, Tomas, Horakova, Dana, Kubala Havrdova, Eva, Weinstock-Guttman, Bianca, Lechner Scott, Jeanette, Boz, Cavit, Sa, Maria, Gresle, Melissa, Butzkueven, H, van der Walt, A, Zhu, C, MSBASE study group,, Buzzard, Katherine, Zhong, Michael, Yeh, Wei Zhen, Jokubaitis, Vilija, Monif, Mastura, Skibina, Olga, Ozakbas, Serkan

Comparing the effectiveness, safety and tolerability of interventions for depressive symptoms in people with multiple sclerosis: A systematic review

- Campese, Stephanie, Lyons, Julia, Learmonth, Yvonne C., Metse, Alexandra, Kermode, Allan G., Marck, Claudia H., Karahalios, Amalia

Improvement of the thalamocortical white matter network in people with stable treated relapsing-remitting multiple sclerosis over time

- Alshehri, Abdulaziz, Koussis, Nikitas, Al-Iedani, Oun, Khormi, Ibrahim, Lea, Rodney, Ramadan, Saadallah, Lechner-Scott, Jeannette

Longitudinal epidemiology of multiple sclerosis over 60 years in Newcastle, Australia: 1961 to 2021

- Simpson-Yap, Steve, Maltby, Vicki E., Lechner-Scott, Jeannette, Hall, Stacey, Ward, Sophia, Lea, Rodney, Boggild, Mike, Kalincik, Tomas, Shaw, Cameron, Taylor, Bruce, van der Walt, Anneke

Multi-modal neuroimaging signatures predict cognitive decline in multiple sclerosis: A 5-year longitudinal study.

- Al-iedani, Oun, Lea, Stasson, Alshehri, A., Maltby, Vicki E., Saugbjerg, Bente, Ramadan, Saadallah, Lea, Rodney, Lechner-Scott, Jeannette

Multimodal neuroimaging signatures of disease characterization and correlation in multiple sclerosis

- Khormi, Ibrahim

No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry

- Campagna, Maria Pia, Havrdova, Eva Kubala, van der Walt, Anneke, Butzkueven, Helmut, Jokubaitis, Vilija G., Horakova, Dana, Izquierdo, Guillermo, Matesanz, Fuencisla, Eichau, Sara, Lechner-Scott, Jeanette, Taylor, Bruce Multiple sclerosis, disease severity, genetics., Garcia-Sanchez, Maria-Isabel, Alcina, Antonio

Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme

- Hardy, T. A., Aouad, P., Lee, A., Malhotra, R., Mccombe, P., Parratt, J., Plummer, C., Van Der Walt, A., Martel, K., Walker, R. A., Barnett, M. H., Blum, S., Broadley, S., Carroll, W. M., Crimmins, D., Griffiths, D., Hodgkinson, S., Lechner-Scott, J.

Patient-determined disease steps is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis

- Foong, Yi Chao, Merlo, Daniel, Darby, David, Dobay, Pamela, van Beek, Johan, Hyde, Robert, Butzkueven, Helmut, van der Walt, Anneke, Gresle, Melissa, Zhu, Chao, Buzzard, Katherine, Lechner-Scott, Jeannette, Barnett, Michael, Taylor, Bruce, Kalincik, Tomas, Kilpatrick, Trevor

The dilated cortical veins found in multiple sclerosis can explain the reduction in glymphatic flow

- Bateman, Grant A., Bateman, Alexander R.

The dilated veins surrounding the cord in multiple sclerosis suggest elevated pressure and obstruction of the glymphatic system

- Bateman, Grant A., Bateman, Alexander R.

The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial

- Yeh, Wei Zhen, Gresle, Melissa, Sampangi, Sandeep, Campagna, Maria Pia, Stankovich, Jim, Van der Walt, Anneke, Jokubaitis, Vilija, Butzkueven, Helmut, Lea, Rodney, Taylor, Bruce, Lucas, Robyn M., Ponsonby, Anne-Louise, Mason, Deborah, Andrew, Julie, Campbell, Hamish, Morahan, Julia

The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-Associated disease

- Liyanage, Ganesha, Trewin, Benjamin P., Buckland, Ali, Fok, Anthony, Barnett, Michael H., Reddel, Stephen W., Marignier, Romain, El Hajj, Aseel, Monif, Mastura, van der Walt, Anneke, Lechner-Scott, Jeannette, Kermode, Allan G., Lopez, Joseph A., Kalincik, T, Broadley, SA, Dale, RC, Ramanathan, S, Brilot, F, Andersen, Jane, Tea, Fiona, Merheb, Vera, Nguyen, Kristy, Lee, Fiona X. Z., Fabis-Pedrini, Marzena J., Zou, Alicia

A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry

- Spelman, Tim, Ozakbas, Serkan, Soysal, Aysun, Kuhle, Jens, Sanchez-Menoyo, Jose Luis, Morgado, Yolanda Blanco, Spitaleri, Daniele L. A., Pesch, Vincent Van, Horakova, Dana, Ampapa, Radek, Patti, Francesco, Macdonell, Richard, Alroughani, Raed, Al-Asmi, Abdullah, Gerlach, O, Oh, J, Altintas, A, Tundia, N, Wong, SL, Butzkueven, H, MSBase Study Group,, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Der Walt, Anneke Van, Yamout, Bassem, Lechner-Scott, Jeannette

A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study

- Saul, Alice M., Taylor, Bruce V., Lechner-Scott, Jeanette, van der Mei, Ingrid, Blizzard, Leigh, Simpson-Yap, Steve, Oddy, Wendy H., Shivappa, Nittin, Hébert, James R., Black, Lucinda J., Ponsonby, Anne-Louise, Broadley, Simon A.

CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis

- Khormi, Ibrahim, Al-iedani, Oun, Casagranda, Stefano, Papageorgakis, Chirstos, Alshehri, Abdulaziz, Lea, Rodney, Liebig, Patrick, Ramadan, Saadallah, Lechner-Scott, Jeannette